Clinical trials sponsored by Hunan Cancer Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Hunan Cancer Hospital

• A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
  NCT05940532 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .
  NCT06734533 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
  NCT07314216 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
  NCT06840704 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
  NCT07073755 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
  NCT05535413 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
  NCT06385990 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many trials is Hunan Cancer Hospital recruiting for?

Hunan Cancer Hospital is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.